These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 28035935)

  • 1. Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.
    Brandscheid C; Schuck F; Reinhardt S; Schäfer KH; Pietrzik CU; Grimm M; Hartmann T; Schwiertz A; Endres K
    J Alzheimers Dis; 2017; 56(2):775-788. PubMed ID: 28035935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.
    Zhang L; Wang Y; Xiayu X; Shi C; Chen W; Song N; Fu X; Zhou R; Xu YF; Huang L; Zhu H; Han Y; Qin C
    J Alzheimers Dis; 2017; 60(4):1241-1257. PubMed ID: 29036812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's Disease Histological and Behavioral Manifestations in Transgenic Mice Correlate with Specific Gut Microbiome State.
    Shen L; Liu L; Ji HF
    J Alzheimers Dis; 2017; 56(1):385-390. PubMed ID: 27911317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer's Disease.
    Dunham SJB; McNair KA; Adams ED; Avelar-Barragan J; Forner S; Mapstone M; Whiteson KL
    mBio; 2022 Dec; 13(6):e0179422. PubMed ID: 36468884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease.
    Richard BC; Kurdakova A; Baches S; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 45(4):1223-36. PubMed ID: 25697701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin changes at the early stage of 5XFAD mice.
    Gu L; Wu D; Tang X; Qi X; Li X; Bai F; Chen X; Ren Q; Zhang Z
    Brain Res Bull; 2018 Mar; 137():285-293. PubMed ID: 29288735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Testosterone Level and Urine Scent Marking in Male 5xFAD Alzheimer Model Mice.
    Gadomsky L; Dos Santos Guilherme M; Winkler J; van der Kooij MA; Hartmann T; Grimm M; Endres K
    Curr Alzheimer Res; 2020; 17(1):80-92. PubMed ID: 32065104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMN synbiotics intervention modulates gut microbiota and metabolism in APP/PS1 Alzheimer's disease mouse models.
    Zhang J; Zhao X; Xu H; Liu X; He Y; Tan X; Gu J
    Biochem Biophys Res Commun; 2024 Sep; 726():150274. PubMed ID: 38924882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor function deficits in the 12 month-old female 5xFAD mouse model of Alzheimer's disease.
    O'Leary TP; Robertson A; Chipman PH; Rafuse VF; Brown RE
    Behav Brain Res; 2018 Jan; 337():256-263. PubMed ID: 28890389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomic analysis of the hippocampus in the 5XFAD mouse model at early stages of Alzheimer's disease pathology.
    Hong I; Kang T; Yoo Y; Park R; Lee J; Lee S; Kim J; Song B; Kim SY; Moon M; Yun KN; Kim JY; Mook-Jung I; Park YM; Choi S
    J Alzheimers Dis; 2013; 36(2):321-34. PubMed ID: 23603400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
    J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer's disease.
    Mezö C; Dokalis N; Mossad O; Staszewski O; Neuber J; Yilmaz B; Schnepf D; de Agüero MG; Ganal-Vonarburg SC; Macpherson AJ; Meyer-Luehmann M; Staeheli P; Blank T; Prinz M; Erny D
    Acta Neuropathol Commun; 2020 Jul; 8(1):119. PubMed ID: 32727612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer's disease.
    Sethi M; Joshi SS; Webb RL; Beckett TL; Donohue KD; Murphy MP; O'Hara BF; Duncan MJ
    Neuroscience; 2015 Apr; 290():80-9. PubMed ID: 25637807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice.
    Zhang Z; Tan X; Sun X; Wei J; Li QX; Wu Z
    J Nutr; 2022 Jan; 152(1):140-152. PubMed ID: 34636875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages.
    Devi L; Ohno M
    Neuroscience; 2015 Oct; 307():128-37. PubMed ID: 26314636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome.
    Chen J; Zou C; Guan H; Zhou X; Hou L; Cui Y; Xu J; Luan P; Zheng D
    CNS Neurosci Ther; 2024 Jul; 30(7):e14823. PubMed ID: 38992870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer's disease.
    Li Z; Zhu H; Guo Y; Du X; Qin C
    J Neurochem; 2020 Nov; 155(4):448-461. PubMed ID: 32319677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
    Kesika P; Suganthy N; Sivamaruthi BS; Chaiyasut C
    Life Sci; 2021 Jan; 264():118627. PubMed ID: 33169684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.